Italia markets open in 3 hours 53 minutes

Teva Pharmaceutical Industries Limited (TEVJF)

Other OTC - Other OTC Prezzo differito. Valuta in USD.
Aggiungi a watchlist
8,74+0,74 (+9,25%)
Alla chiusura: 09:31AM EDT
Schermo intero
I prezzi di scambio non provengono da tutti i mercati
Chiusura precedente8,00
Aperto8,74
DenaroN/D x N/D
LetteraN/D x N/D
Min-Max giorno8,74 - 8,74
Intervallo di 52 settimane7,00 - 11,95
Volume100
Media Volume459
Capitalizzazione10,196B
Beta (5 anni mensile)1,27
Rapporto PE (ttm)N/D
EPS (ttm)-0,56
Prossima data utiliN/D
Rendimento e dividendo (forward)N/D (N/D)
Data ex dividendo28 nov 2017
Stima target 1AN/D
  • GlobeNewswire

    Certara Appoints Rosemary Crane as New Independent Board Member

    PRINCETON, N.J., July 25, 2022 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the appointment of Rosemary Crane to its Board of Directors, effective July 21, 2022. Her appointment brings the company’s board of directors to eleven members. “We are excited to welcome an accomplished business leader with a proven track record of success join Certara’s Board,” said William F. Feehery, PhD, CEO of Certara. “Rose’s experience in executive leadership

  • GlobeNewswire

    Quantum Genomics signs an exclusive license agreement with Teva Israel Ltd.

    Quantum Genomics will receive up to $11 M in payments and 25% minimum up to 30% royalties on future salesTeva will receive an exclusive license to bring firibastat to its home market, Israel PARIS, Nov. 25, 2021 (GLOBE NEWSWIRE) -- Quantum Genomics (Euronext Growth – FR0011648971 – ALQGC), a biopharmaceutical company specializing in the development of a new drug class directly targeting the brain to treat difficult-to-treat/resistant hypertension, has today announced the signing of an exclusive